Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-inferiority Trial of Oral Tranexamic Acid (OTA) vs. Intravenous Tranexamic Acid (IVTA) to Prevent Blood Loss in Joint Replacement Surgery

NCT02438566 is registered in ClinicalTrials.gov with The New England Baptist Hospital as lead sponsor.

NCT NCT02438566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02438566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-inferiority Trial of Oral Tranexamic Acid (OTA) vs. Intravenous Tranexamic Acid (IVTA) to Prevent Blood Loss in Joint Replacement Surgery
Lead sponsor
The New England Baptist Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
April 30, 2015
Completion date
April 30, 2017
Enrollment
118 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood loss, postoperative, blood loss, surgical, osteoarthritis